Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents-Reference-Cited by-同舟云学术

Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents

Published:2000-06 Issue:6 Volume:5 Page:241-252
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Meanwell Nicholas A,Krystal Mark

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference107 articles.

1. Recovery of cytopathogenic agent from chimpanzees with coryza;Morris;Proc. Soc. Exp. Biol. Med.,1956

2. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization;Chanock;Am. J. Hyg.,1957

3. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiological aspects of infection in infants and young children;Chanock;Am. J. Hyg.,1957

4. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery;Ottolini;Drugs,1997

5. Respiratory syncytial virus (RSV) disease and prospects for its control;Wyde;Antiviral Res,1998

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isatin derivatives as broad-spectrum antiviral agents: the current landscape;Medicinal Chemistry Research;2022-01-13

2. The Novel [4,5-e][1,3]Diazepine-4,8-dione and Acyclic Carbamoyl Imino-Ureido Derivatives of Imidazole: Synthesis, Anti-Viral and Anti-Tumor Activity Evaluations;Molecules;2013-10-30

3. Antiviral Drug Discovery;Drug Discovery;2013-04-09

4. The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures;Medicinal Research Reviews;2010-12-13

5. N-(3-Cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicity;Journal of General Virology;2010-08-04